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Abstract
Given the growing issue in healthcare of antibiotic resistance, effective and safe
alternative treatment methods are required. One of these possible alternative treatment methods
is bacteriotoxins including bacteriocins and tailocins. The focus of this study is a bacteriotoxin
from Burkholderia cenocepacia (ATCC 25608), which was induced for toxin using a modified
UV light induction procedure and tested against a variety of Pseudomonas and Burkholderia for
its killing capacity. Various other pathogenic strains were then induced with UV light and tested.
The results showed that the toxin from ATCC 25608 was very effective against most of the
Burkholderia tested and warrants further study for possible clinical use. The pathogenic
Burkholderia strains tested, however, did not produce any affective toxin against the indicator
cells used in the study. The study also indicated that storage of toxin is most effective at 4°C,
whereas storage in glycerol at -20°C appears to limit the toxin’s effectiveness.

Introduction & Literature Review
Antibiotic Resistance: A Growing Problem in Healthcare
Since the inception of the use of antibiotics in the treatment of bacterial infections,
antibiotic resistance has been a developing problem. In modern medicine, antibiotic resistance is
an increasingly present threat to the current treatment methods for many diseases. Harold
Brüssow of the Nestle Research Center explains how the number of organisms which have begun
to show resistance to antibiotics is increasing and there are a “sizeable number of patients” which
are no not able to receive any antibiotic treatment because the pathogen is resistant to all
currently available antibiotics (Brüssow, 2017). For that reason, alternative treatment methods
must be proposed and validated in order to address the issue and continue with effective
treatments for bacterial infections. One of the most prominent examples of the need for
alternative treatment methods is cystic fibrosis (CF) patients. As a result of the pathology of CF,
patients are left susceptible to a variety of respiratory tract infections, both nosocomial and other.
One of these opportunistic pathogens which is most problematic in CF patients is Burkholdaria
cenocepacia, a member of the Burkholderia cepacian complex (BCC), which is a group of 17
species of bacteria that are incredibly closely related genetically (Drevinek, Mahenthiralingram,
2010). Due to the high prevalence of this bacteria in CF patients and its resistance to antibiotics,
it therefore becomes an attractive subject for study into alternative treatment methods. Another
bacterium of concern is Pseudomonas aeruginosa, which is a very common opportunistic
pathogen in CF patients. The reason for which P. aeruginosa is so problematic relates to B.
cenocepacia, in that it demonstrates strong antibiotic resistance. At the same time, it can also
acquire adaptive mutations during the course of infection in chronic cases, such as those in CF
patients (Malhotra, et al, 2019).

Tailocins
Given the already established problem of antibiotic resistance, one possible solution is
the use of tailocins and other protein toxins in place of antibiotics. These proteins produced by
the ribosomes of some bacterial cells can function similar to antibiotics in that they can kill
competing, and often closely related cells (Behren, et al, 2017). A study by Vacheron et al,
supported this idea by showing that phylogenetic distance is mirrored in the tailocins produced
by Pseudomonas, as the tailocins tend to be designed with the intention of killing closely related
species, while leaving those more phylogenetically distant unharmed (Vacheron, et al, 2021).The
antibacterial functions of these toxins are therefore attractive and worthy of research in order to
determine if certain tailocins can be identified for problematic bacterial species, as well as if
these tailocins carry the same function in vivo as they do in vitro. Particularly, tailocins which are
capable of killing opportunistic pathogens in CF are of interest in order to combat the dwindling
list of treatment options. In a general sense, tailocins can be broke down into R-type (rigid) and
F-type (flexible) pyocins. Both of these pyocins are non-replicating, as they do not contain any
genetic material. R-type pyocins are able to kill target cells by a process known as “single-hit
membrane depolarization”, where a single unit of the pyocin can cause death of the entire cell.
This very narrow-range specificity is in large part what makes R-pyocins so attractive as a
potential non-antibiotic therapy (Oluyombo, et al, 2019). R-type and F-type pyocins can be
differentiated in the sense that R-type are similar to non-flexible and contractile phage tails,
whereas F-type are flexible and non-contractile. Fernandez et al, demonstrated the mechanism of
action that R-type pyocins utilize to kill target cells. They showed that R-type pyocins bind to
receptor sites on the lipopolysaccharide core and then form a channel into the bacterial
membrane, thus allowing them to kill the cell (Fernandez, et al, 2017). Some have gone as far as

to propose the possibility of tailocins becoming candidates for engineering, similar to phage
engineering, in order to create a specific antibacterial spectrum such that the tailocin kills the
desired target cell (Kim, et al, 2019).

Bacteriocins
Bacteriocin is a more general term used for antimicrobial peptides synthesized by some
bacteria in order to kill competing bacteria. These bacteriocins can be either class I, meaning
they undergo post-translational modifications, or class II, which remain unchanged posttranslation. Bacteriocins can exhibit either broad or narrow-spectrum activity, similar to
antibiotics. The specificity of the bacteriocin carries some clinical significance, as narrower
spectrum bacteriocins are often preferred in order to maintain the rest of non-pathogenic
bacterial community (Zheng, Sonomoto, 2018). Much of the knowledge of bacteriocins comes
from that produced by Escherichia Coli, known as a colicin. They function by first binding to a
receptor on the cell membrane, where they are then translocated through the periplasmic space
via Tol or TonB systems. Once beyond the periplasmic space, colicins can either form a voltagedependent channel or they can cut the phosphodiester bond on the polynucleotide chain in either
DNA, RNA, or tRNA, thus resulting in cell death (Cascales, et al, 2007).

Bacteriocins and Tailocins in Burkholderia and Pseudomonas
Pyocins have been shown to be produced by over 90% of P. aeruginosa strains, while it
is also worthy of noting that some strains can produce multiple different pyocins. Production of
these pyocins is known to be stimulated by the presence of mutagenic agents, including but not
limited to mitomycin C and UV radiation. It is also important to consider that strains which are

capable of producing a pyocin are therefore not sensitive to that pyocin, as would be expected
(Michel-Briand, Baysse, 2002). With regard to Burkholderia, one study demonstrated the ability
of B. cenocepacia strain BC0425 to produce a tailocin (BceTMilo), which could kill 68% of Bcc
as well as 90% of non-Bcc Burkholderia (Yao, et al, 2017). Given the previously established
clinical significance of these two bacteria and their significant role in human disease,
understanding the nature and function of the bacteriocins produced by these bacteria as well as
their effective range of the toxin is a necessary first step towards understanding how they may be
used as an antibiotic alternative.

Research Questions
This project seeks to answer multiple research questions, as follows: First, the project
seeks to determine a procedure for the induction of bacteriocins by B. cenocepacia (ATCC
25608) and determine the ideal induction methods. The lab of Dr. Ray Larsen at Bowling Green
State University has previously identified a strain of B. cenocepacia which, when induced by UV
light, is capable of producing a bacteriotoxin which shows promise in its antimicrobial function.
This particular bacterium is of interest because of the role it plays as an opportunistic pathogen,
particularly in CF patients. The project also seeks to determine ideal storage methods for the
bacteriotoxin, including comparisons between refrigerator storage at 4°C and freezer storage at
-20°C with glycerol. In addition, the project seeks to determine the maximum dilution range of
the bacteriotoxin by utilizing serial dilutions, which should provide the limits of the effective
range of the toxin. Finally, the effectiveness of the toxin with regard to its antimicrobial
properties against various species and strains of Burkholderia as well as Pseudomonas is sought
after in this project. It is crucial to know the extent to which the toxin is functional as an

antibiotic against different strains, and which strains it is most effective in killing. Establishing
this will allow for a basis on which to build in order to determine if the in vitro results can be
replicated in terms of both effectiveness and safety in vivo. These same strategies will also be
used to attempt to induce toxin from various pathogenic Burkholderia and determine if they
show the same killing capacity.

Methods
Preliminary Trials-Establishing Sensitivity to Toxins
Utilizing samples of toxin from by B. cenocepacia (ATCC 25608) produced previously
in the lab of Dr. Ray Larsen by Kudus Ghebretinsae, the sensitivity which certain strains showed
to the toxin as well as the ideal induction times and concentrations could be determined. In order
to do so, 100 L samples of Burkholderia thailandensis, B. cenocepacia (ATCC 25608), B.
cenocepacia (ATCC 25416), P. aeruginosa (unknown strain number), and P. aeruginosa (ATCC
22853) were plated separately on LB plates in 3 mL of LB top agar. Plates were then spotted
with 5 L of toxin produced by P. aeruginosa as well as B. cenocepacia. Samples from UV
induction times of 0, 15, 30, and 45 seconds were utilized for spotting on each plate. These
results showed the clear effectiveness of the B. cenocepacia (ATCC 25608) toxin against B.
thailandensis as well as the optimized toxin strength at UV induction times of 15 and 30
seconds. Knowing that B. thailandensis is susceptible to the toxin produced by B. cenocepacia
(ATCC 25608), this provided a positive control going forward as the production method for the
toxin as well as the effective range of the toxin were tested.

Inducing and Optimizing Production of Bacteriotoxin
The method for induction of toxin by B. cenocepacia (ATCC 25608) was modified and
adapted from a procedure utilized by Kudus Ghebretinsae. One mL samples of B. cenocepacia
(ATCC 25608) were centrifuged at 20,000 rcf for 4 minutes. The supernatant was then discarded
and the pellet was resuspended in 1 mL of 0.1 M MgSO4. The resuspended sample was then
plated on a UV translucent plate with 4 mL of 0.1 M MgSO4. An initial 1 mL sample was
collected and designated as the “0 second” induction time sample. Additional 1 mL samples
were then collected after 15 second, 30 seconds, and 45 seconds of exposure to UV light with a
wavelength of 254 nm. Each of the four samples (0, 15, 30, 45) were then combined with 4 mL
of fresh LB broth and shaken at 37C overnight. At this point, 1.5 mL samples were collected
from each of the 4 tubes and then centrifuged at 20,000 rcf for 4 minutes, after which the
supernatant was collected. The supernatant of each sample was then treated with 2 drops of
chloroform so as to assure the cells undergo lysis. Finally, the solution was filter sterilized to
ensure no contaminants were present. This process was completed with two different cultures of
B. cenocepacia (ATCC 25608): one new (fresh 48-hour culture), and one old (stored at room
temperature for 7-10 days).
In order to determine the effectiveness of this process, a plate of B. thailandensis was
made by combining 100 L of B. thailandensis with 3 mL of T-top agar and then plated on Tplate. The plate was spotted with 5 L of the 0 second, 15 second, 30 second, and 45 second
induced samples of toxin, with the 30 second toxin from the preliminary trials being used as a
positive control and 1:4 MgSO4/LB broth serving as the negative control.
After the toxin samples were shown to be effective in killing B. thailandensis, thus
confirming toxin had been induced, five-fold serial dilutions of each sample were then prepared

out to 5-8 in order to determine the effective concentration range. Four plates of B. thailandensis
were then prepared using the same previously established procedure, with each being spotted
with 5 L of the 8 serial dilutions from one of the samples (0, 15, 30, 45 seconds). Again, 1:4
MgSO4/LB broth was used as a negative control.

Determining Ideal Storage Methods for Toxin
One of the important aspects to consider after production of the toxin from B.
cenocepacia (ATCC 25608) is how to ideally store it so as to maximize it strength over an
extended period of time. In order to do so, storage at 4°C was compared to storage at -20°C, with
glycerol being added only to the second sample to prevent the toxin-solution from freezing.
Using the previously established procedure, additional toxin was induced from B.
cenocepacia (ATCC 25608). After induction, 500 L of each of the 4 samples was taken and
each was combined with 500 L of 50% glycerol solution. The original samples were then stored
in a refrigerator at 4°C, while the samples with glycerol were stored in a freezer at -20°C. The
30-second induction samples from the original as well as those with glycerol were then further
examined, since they showed strongest effectiveness, by preparing 5-fold dilutions out to 5-4.
Five plates of PA ATCC, PA MT, B. cenocepacia (ATCC 25608), B. cenocepacia (ATCC
25416) , and B. thailandensis (ATCC 700308) were then prepared using the previouslymentioned procedure. Each was spotted with the four serial dilutions as well as undiluted
samples of the regular toxin and the toxin stored with glycerol. Due to differences in
concentration, 5 L samples of the regular toxin sample and 10 L of the sample with glycerol
were spotted.

Testing Broad-Spectrum Effectiveness of B. cenocepacia (ATCC 25608) Toxin
In order to begin testing the range of the effectiveness of the bacteriotoxin, the 30-second
induction sample without glycerol was tested first against two strains of Pseudomonas (AU
17787, AU 12176) both of which are clinical isolates. Five-fold dilution out to 5-4 were prepared
and then 5 L samples of the dilutions as well as an undiluted sample were spotted on 4 T-plates,
with each containing one of the 2 Pseudomonads of interest. The T-plates with the
Pseudomonads being tested for susceptibility to the toxin were prepared using the same
established procedure.
In order to further understand the killing capacity of the toxin produced by B.
cenocepacia (ATCC 25608), several samples of pathogenic Burkholderia were prepared. This
process included first streaking T-plates with each strain and leaving them in an incubator at
37C overnight. Upon observing growth and isolation of individual colonies, growth medium to
create overnight broth cultures were inoculated and then shaken at 37C. Of note, the strains AU
28891, AU 32676, and AU 30447 did not demonstrate any significant growth overnight and were
instead left in the incubator to grow over the course of 3 days, at which point broth cultures of
each could then be prepared.
Following preparation of broth cultures, each was then tested for its susceptibility to the
bacteriotoxin. This was done again by plating 100 L of each bacteria in 3 mL of T-top agar, as
well as aqueous CaCl in a 1:10 ratio, on T-plates. Each was then spotted with 5 L samples of
the 30 second-induced toxin, this time in 2-fold serial dilutions using phage buffer (10 mM Tris
pH 7.8, 20 mM MgSO4, CaCl 5 mM) to 2-7. Table 1 indicates all of the bacterial strains which
were included in the study.

Table 1. List of Bacterial Strains Analyzed for Susceptibility to B. cenocepacia 25608 Toxin
(P. aeruginosa Clinical Isolates From Dr. John LaPuma U of M)
Pathogen Name
B. cenocepacia
B. cenocepacia

Strains from Burkholderia
Strain No.
Source
ATCC 25608
Laboratory Strain
AU 30232
Clinical Isolate

Pathogen Name
P. aeruginosa 28
P. aeruginosa 29

Strains from Pseudomonas
Strain No.
Source
AU 17787
Clinical Isolate
AU 12176
Clinical Isolate

B. cenocepacia

AU 22104

Clinical Isolate

P. aeruginosa

Unknown

Laboratory Strain

B. cenocepacia
B. cepacia
B. multivorans

AU 30376
AU 31398
AU 34312

Clinical Isolate
Clinical Isolate
Clinical Isolate

P. aeruginosa

ATCC 27853

Laboratory Strain

B. multivorans

AU 21833

Clinical Isolate

B. dolosa

AU 21952

Clinical Isolate

B. cepacia

ATCC 25416

Lab Strain

B. thailandensis

ATCC 700388

Lab Strain

Inducing and Testing Toxin from Various Burkholderia Strains
Upon testing the efficacy of the toxin from B. cenocepacia (ATCC 25608) against
various pathogenic strains of Burkholderia, the natural progression was to attempt to induce
toxin from some of these strains and test the killing spectrum of these toxins against the other
pathogenic Burkholderia. The strains which were selected for study with respect to toxin
production by UV light was based on facility of growth in overnight broth cultures. Overnight
LB broth cultures of were inoculated and shaken at 37ºC. Ideal growth was observed for four
strains (AU 30232, AU 34312, AU 21952, AU 21833). At this point, the same UV light
induction procedure as with B. cenocepacia (ATCC 25608) was utilized, with the exception of
the induction times. As opposed to taking 0s, 15s, 30s, and 45s induction-time samples, all four
strains were exposed to UV light for 30 seconds and samples were taken at this time only. This
was based on the results seen in the spot assays for B. cenocepacia (ATCC 25608) toxin, in
which the 30-second induction appeared to be most effective. At this point, spot assays were
performed with two-fold dilutions to 2-7 of each toxin. Assays were performed testing the

susceptibility of each of the four producing strains to the its own toxin as well as those of the
other three strains.

Results and Discussion
Establishing Sensitivity to Toxin
In the initial trials utilizing toxin from B. cenocepacia (ATCC 25608) as well as P.
aeruginosa prepared previously in the lab by Kudus Ghebretinsae, the B. cenocepacia toxin was
shown to be most worthy of further investigation. At the same time, B. thailandensis appeared
susceptible to the toxin, particularly the 15 second and 30 second-induced samples. The plates
containing B. cenocepacia (ATCC 25416), B. cenocepacia (ATCC 25608), and P. aeruginosa
exhibited no sensitivity to either of the toxins, regardless of induction time. Very light clearing
zones were seen for each variation of both toxins in the assay for P. aeruginosa (ATCC 27853).
B. thailandensis indicated strong susceptibility to both the 15 and 30 second-induced samples of
the B. cenocepacia (ATCC 25608) toxin, with rather large zones of clearing, particularly for the
15-second induction (Appendix A). Thus, going forward in this experiment, B. cenocepacia
(ATCC 25608) was utilized for induction of bacteriotoxin, while B. thailandensis served as a de
facto positive control in order to determine both if toxin had been produced as well as how
strong it was.

Image 1: Spot assay against B. thailandensis shows 15 and 30 second samples of toxin from
ATCC 25608 are effective in inhibiting growth.

Induction of Bacteriotoxin from B. cenocepacia (ATCC 25608) using UV Light
After inducing the toxin, it was shown to be very effective against B. thailandensis in the
15 and 30 second samples from the new culture, with the 0 and 45 showing only faint zones of
clearing. The toxin from the old culture showed very faint clearing zones as well for 0 and 30
second samples, with effectively no killing in the 15 and 45 second samples (Appendix B). This
is indicative that the freshness of the B. cenocepacia culture being utilized for induction of toxin
has a significant impact on the potency of the toxin which is produced.

Image 2: Toxin from ATCC 25608 produced by fresh strain (top row) is effective in
15 and 30 second samples in inhibiting growth of B. thailandensis.
Upon completing this initial screening assay to determine that the toxin had been
produced as well as determine which sample was most effective, additional trials run using B.

thailandensis showed the effective concentration range of each toxin sample. The assay run with
the 0 second induction sample showed no killing at any concentration. The 15 second sample
showed significant killing at 5-1, moderate clearing at 5-2, light clearing at 5-3, and no
effectiveness at at any dilution beyond 5-3. The 30 second induction toxin sample also showed no
effectiveness beyond a dilution of 5-3. However, the clearing was significant at both 5-1 and 5-2
dilutions, with only moderate clearing in the 5-3 dilution. Finally, the 45 second induction sample
demonstrated significant clearing in the 5-1 dilution, light clearing in the 5-2 dilution, and no
clearing at any dilution beyond this (Appendix C).

Image 3: 30 second sample from ATCC 25608 is effective against B. thailandensis to 5-3
dilution.

These results indicate that 30 second induction time appears to be ideal for induction of
bacteriotoxin from B. cenocepacia (ATCC 25608). At the same time, it appears that the
maximum dilution for the toxin produced in this procedure in order to still see some degree of
killing is 5-3, with 5-2 being the maximum dilution of the 30 second sample if strong killing
capacity is desired. For the 15 and 45 second samples, any dilution beyond 5-1 appears to greatly
reduce the killing capacity of the toxin, and therefore this would seem to be the maximum
dilution for those samples.

Testing Different Storage Methods for Toxin
The trials comparing the 30 second-induced toxin stored without glycerol at 4°C and the
30 second-induced toxin stored with 50% glycerol at -20°C indicated that storage at -20°C with
glycerol appears to reduce the effectiveness of the toxin. In the assay run with B. thailandensis,
which has previously been established to be sensitive to the toxin, the sample stored in glycerol
was only effective in its undiluted form, while the sample without glycerol was effective to 5-3
dilution (Appendix E). Thus, storage of the toxin in glycerol solution and reduced temperatures
appears to not be ideal as compared to storage in the 1:4 MgSO4/LB Broth solution.

Image 4: Storage in glycerol at -20°C (top row) greatly reduces effectiveness of toxin from
ATCC 25608 when compared to storage without glycerol at 4°C (bottom row).

Determining Sensitivity of Various Additional Bacterial Species and Strains
In addition to the results which were seen for sensitivity of certain strains when testing
the storage methods, additional assays were done solely to determine panel-wide sensitivity to
the toxin. Sensitivity assays run for clinical isolates AU 12176 and AU 17787 indicated
sensitivity to the undiluted 30 second-induced toxin from B. cenocepacia (ATCC 25608)
(Appendix D). There was some clearing seen in the 5-1 dilution, however it was significantly less
than that seen in the undiluted sample. This indicates that for these two specific clinical isolates
of P. Aeruginosa from CF patients, the toxin appears to have a significant killing capacity.

Experiments testing against B. cepacia (ATCC 25416), B. cenocepacia (ATCC 25608),
P. aeruginosa (ATCC 27853) , and P. aeruginosa (unknown strain) indicated that the toxin has
no effect on any of these bacteria. No clearing zones were seen in any of the assays run,
regardless of degree of dilution (Appendix E). As expected, however, significant clearing was
seen in the assay run with B. thailandensis in every dilution out to 5-3, thus demonstrating that
the negative results seen in the other assays were indicative of resistance and not any sort of
impurity of the toxin. Additional assays using various Burkholderia were also run with 2-fold
serial dilutions of the 30-second toxin. Table 2 is a summary of these results, which are shown in
Appendix F.

Table 2. Results for Panel of Various Burkholderia cepacia complex strains treated with
ATCC 25608 toxin
Indicator cells

Susceptibility to ATCC 25608 Toxin

B. cenocepacia

2-1
+

2-2
+

2-3
+

2-4
+

2-5
+

2-6
+

2-7
+

(AU 30232)
B. cenocepacia

+

+

+

+

+

+

+

(AU 22104)
B. cenocepacia

+

+

+

+

+

-

-

(AU 30376)
B. cepacia

-

-

-

-

-

-

-

(AU 31398)
B. multivorans

+

+

+

+

+

+

-

(AU 34312)
B. multivorans

+

+

+

+

+

+

-

(AU 21833)
B. dolosa

+

+

+

+

+

-

-

(AU 21952)

The toxin appeared to demonstrate at least some killing capacity against all strains, with
the exception of AU 34312. Clearing was seen out to 2-5 dilution for AU 30376 and AU 21952.

Clearing was present out to 2-6 dilution for AU 34312 and AU 21833. Finally, clearing existed in
the assay out through the maximum dilution, 2-7, for AU 30232 and AU 22104. This is indicative
that the toxin is effective against several pathogenic strains to a seemingly significant degree,
with at least five 2-fold dilutions being required before its efficacy appears to decrease below the
qualifiable threshold.

Determining Effectiveness of Toxins from Various Burkholderia
Upon running spot assays for each of the four newly induced toxins against each of the
producing strains of Burkholderia, results for each assay showed no activity, regardless of degree
of dilution (Appendix G). The two most likely possible explanations pertain to the effectiveness
of the toxin or the lack of the ability of each strain to produce a toxin by UV induction. Each of
the four strains of Burkholderia may produce a toxin that is ineffective against the four teststrains utilized in this study. At the same time, the strains may not produce any toxin at all,
which could also lead to the lack of activity. It is important to note that a combination of these
two explanations is possible as well. The results are shown below in Tables 3-6.

Image 5: Spot assays for toxins induced from various pathogenic strains of Burkholderia
indicate toxin is not produced or not effective against indicator cells.

Table 3. Results of spot assays for ATCC 21833 toxin against four Burkholderia species.
Indicator cells

Susceptibility to ATCC 21833 Toxin

B. cenocepacia

2-1
-

2-2
-

2-3
-

2-4
-

2-5
-

2-6
-

2-7
-

(AU 30232)
B. multivorans

-

-

-

-

-

-

-

(AU 21833)
B. multivorans

-

-

-

-

-

-

-

(AU 34312)
B. dolosa

-

-

-

-

-

-

-

(AU 21952)

Table 4. Results of spot assays for ATCC 43412 toxin against four Burkholderia species.
Indicator cells

Susceptibility to ATCC 34312 Toxin

B. cenocepacia

2-1
-

2-2
-

2-3
-

2-4
-

2-5
-

2-6
-

2-7
-

(ATCC 30232)
B. multivorans

-

-

-

-

-

-

-

(ATCC 21833)
B. multivorans

-

-

-

-

-

-

-

(ATCC 34312)
B. dolosa

-

-

-

-

-

-

-

(ATCC 21952)

Table 5. Results of spot assays for ATCC 21952 toxin against four Burkholderia species.
Indicator cells

Susceptibility to ATCC 21952 Toxin

B. cenocepacia

2-1
-

2-2
-

2-3
-

2-4
-

2-5
-

2-6
-

2-7
-

(ATCC 30232)
B. multivorans

-

-

-

-

-

-

-

(ATCC 21833)
B. multivorans

-

-

-

-

-

-

-

(ATCC 43412)
B. dolosa

-

-

-

-

-

-

-

(ATCC 21952)

Table 6. Results of spot assays for ATCC 30232 toxin against four Burkholderia species.
Indicator cells

Susceptibility to ATCC 30232 Toxin

B. cenocepacia

2-1
-

2-2
-

2-3
-

2-4
-

2-5
-

2-6
-

2-7
-

(ATCC 30232)
B. multivorans

-

-

-

-

-

-

-

(ATCC 21833)
B. multivorans

-

-

-

-

-

-

-

(ATCC 34312)
B. dolosa

-

-

-

-

-

-

-

(ATCC 21952)

In order to confirm the results seen in the spot assays for the four newly induced toxins,
the indicator cells were tested against the toxin from B. cenocepacia ATCC 25608, with the
expectation that those which were previously susceptible would still be. At the same time, the
trials with B. cenocepacia 25608 indicator cells should not demonstrate activity, which serves as
a negative control. The results from these trials can be seen in Table 7 and appendix H.

Table 7. Results of Spot Assays for ATCC 25608 Toxin against various Burkholderia
Indicator cells

Susceptibility to ATCC 25608 Toxin

B. cenocepacia

2-1
+

2-2
+

2-3
+

2-4
+

2-5
+

2-6
+

2-7
-

(AU 30232)
B. cenocepacia

+

+

+

+

-

-

-

(AU 22104)
B. cenocepacia

-

-

-

-

-

-

-

(ATCC 25608)
B. multivorans

+

+

+

+

+

+

+

(AU 34312)
B. multivorans

+

+

+

+

+

-

-

(AU 21833)
B. dolosa

+

+

+

+

+

+

+

(AU 21952)

The results shown in Table 7 aid in confirming the results from the previous trials using
the four newly induced toxins, as it indicates expected activity from the test strains. Thus, this
helps to rule out any possible defects with the test strains causing the results seen in tables 3
through 6.

Significance
The findings of this study are significant in a multitude of aspects. With respect to toxin
production, the study demonstrates that 30 second UV induction of suspended Burkholderia
appears to be ideal in order to maximize toxin production. Beyond this, the ideal procedure for
production of toxin, at least from ATCC 25608, was established. It appears as though suspension
in a 4:1 mixture of phage buffer and MgSO4 is ideal for induction, whereas the samples can then
be taken and resuspended in LB broth after induction. This procedure, and its most effective
conditions, is important to understand for future research into the toxin produced by ATCC
25608, as well as other related strains.
Additionally, of the storage methods tested for the toxin, refrigeration storage was shown
to be most effective, as storage in glycerol and at lower temperatures appears to reduce the
effectiveness of the toxin. This finding is important, as storage with glycerol at low temperatures
is a common method used to extend the long-term usability of many microorganisms, however it
appears that in this case this method is not practical.
The study also demonstrates the effectiveness of the toxin from ATCC 25608 against a
wide variety of Burkholderia, including many pathogenic strains, as well as some slight
effectiveness against pathogenic P. aeruginosa strains. These findings establish a basis on which

to build in the future regarding study of the toxin from ATCC 25608. Prior to characterizing the
toxin and understanding it more both chemically and genetically, it must first be established that
the toxin shows both a strong killing capacity as well as a range of bacteria which are susceptible
to it. This indicates that the toxin, at least in vitro, functions similar to an antibiotic and is
capable of killing many pathogenic Burkholderia.
Furthermore, these results show that either not all strains of Burkholderia are capable of
producing a toxin similar to that of ATCC 25608, or that different induction methods must be
developed in order to do so. While the induction worked well for ATCC 25608 and the resulting
toxin showed significant effectiveness against a variety of indicator cells, the same methodology
was used for other strains and each was ineffective. Thus, the pathogenic strains used are either
not capable of producing a toxin, or cannot be induced in the same way as the lab adapted strain
used prior.

Future Research
The majority of the future research building on this investigation centers around
understanding the toxin produced by ATCC 25608. While it is most likely that the toxin is a
protein and falls into the category of either a bacteriocin or a tailocin, the 3D protein structure
must be deduced in order to confirm this. At the same time, the mechanism of the toxin must be
understood as well, and could serve as a topic for future research into the toxin. Understanding
by the structure and function of the ATCC 25608 toxin is crucial if it is ever to be investigated
further for potential therapeutic uses as an antibiotic alternative. Related to this is future research
into the genetics of the toxin and what region of the ATCC 25608 genome codes for it. Given
that the genome of ATCC 25608 has not been the subject of much research at all, this is an

important basis for a future project. Once the genetic sequence of the toxin is understood, the
knowledge of its function and possible therapeutic use can be better understood.
In addition to studying the toxin specifically for its structure and function, this study
establishes the need for future research into other strains of Burkholderia and their toxinproducing capabilities, as well as possible alternative methods for toxin induction. It is possible
that other strains may produce toxins which are either stronger or have a wider range than that of
ATCC 25608 and could therefore be even more worthy subjects of further research into possible
applications as antibiotic alternatives.
With respect to storing the toxin, additional methods can be tested and compared to
standard refrigerator storage in LB broth. While this was significantly more effective than
storage at lower temperatures with 50% glycerol, additional methods for storage could be
thought up and tested in order to maximize the long-term effectiveness of the toxin and therefore
prevent the need for constant induction to produce new samples. Similarly, the storage in
glycerol could be further investigated in order to determine why the glycerol and low
temperatures significantly reduces the effectiveness of the toxin.
Finally, in a more crude sense, this study could be built upon by testing more strains of
Burkholderia against the toxin, as well as possibly other strains of Pseudomonas. Continuing to
build on the knowledge of which strains are susceptible to the toxin will help to further
understand the range of the toxin and thus possible future application. Prior to in vivo testing,
having data on a variety of strains in vitro is crucial. Building upon is data is therefore a
worthwhile topic of investigation in the future.

Appendices
Appendix A. 0, 15, 30, and 45 second induction times of toxins from B. cenocepacia (ATCC
25608) and Pseudomonas results against various strains. From left to right B. thailandensis
(ATCC 700308), B. cenocepacia (ATCC 25416), B. cenocepacia (ATCC 25608),
P.aeruginosa (ATCC 27853), P. aeruginosa (unknown strain)

Appendix B. Test of toxin induced at various times (0, 15, 30, 45 seconds) from B.
cenocepacia (ATCC 25608) against B. thailandensis (ATCC 700308). Toxin from new strain
(N) compared to old strain (O).

Appendix C. Five-fold serial dilutions to 5-7 of each toxin (0, 15, 30, and 45 second
induction) from B. cenocepacia (ATCC 25608) tested against B. thailandensis.

0 seconds

15 seconds

30 seconds

45 seconds

Appendix D. Spot Assays of B. cenocepacia (ATCC 25608) toxin against two P. aeruginosa
strains from clinical isolates.

P. aeruginosa 28

P. aeruginosa 29

Appendix E. Spot assays of B. cenocepacia (ATCC 25608) toxin against BCC and PA
strains.

B. thailandensis

P. aeruginosa (Unknown Strain)

P. aeruginosa ATCC 27853

B. cenocepacia (ATCC 25608)

B. cenocepacia (ATCC 25416)

Appendix F. Spot assay results for B. cenocepacia (ATCC 25608) toxin against various
Burkholdaria.

AU 31398

AU 22104

AU 30232

AU 21952

AU 21833

AU 30376

AU 43412

Appendix G. Spot assay results for four induced Burkholderia toxins against five
Burkholderia. Toxin producing strains used in each trial are in parentheses.

AU 30232 (21833, 43412)

AU 21833 (21833, 43412)

AU 43412 (21833, 43412)

AU 21952 (21833, 43412).

AU 21833 (30232, 21952).

AU 30232 (30232, 21952)

AU 34312 (30232, 21952)

AU 21952 (30232, 21952)

Appendix H. Spot assay results for various Burkholderia strains against ATCC 25608
toxin. Results confirm results from Appendix G.

ATCC 25608

AU 22104

AU 34312

AU 30232

AU 21833
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